Company Filing History:
Years Active: 2017
Title: Monika Bokori-Brown: Innovator in Epsilon Toxin Research
Introduction
Monika Bokori-Brown is a distinguished inventor based in Exeter, GB. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides related to epsilon toxins. Her innovative work has implications for vaccine development and disease prevention.
Latest Patents
Monika Bokori-Brown holds a patent for an epsilon toxin epitope polypeptide. This polypeptide comprises a sequence of at least 10 contiguous amino acids from SEQ ID NO:3, featuring a mutation of at least one tyrosine residue compared to the equivalent sequence in SEQ ID NO:3. The polypeptide is capable of binding an antibody that interacts with SEQ ID NO:5 and exhibits reduced toxicity compared to SEQ ID NO:5. This invention is particularly useful in methods of vaccinating subjects against diseases associated with active epsilon toxin.
Career Highlights
Monika is affiliated with the University of Exeter, where she conducts her research and development work. Her academic background and expertise have positioned her as a key figure in her field. She has successfully navigated the complexities of patenting her innovations, ensuring that her contributions are recognized and protected.
Collaborations
Monika has collaborated with notable colleagues, including Richard W Titball and Claire Naylor. These partnerships have enhanced her research efforts and expanded the impact of her work in the scientific community.
Conclusion
Monika Bokori-Brown is a pioneering inventor whose work on epsilon toxin polypeptides is paving the way for advancements in vaccine development. Her contributions to biotechnology are invaluable, and her collaborations further amplify the significance of her research.